Baseler Laura, Scott Dana P, Saturday Greg, Horne Eva, Rosenke Rebecca, Thomas Tina, Meade-White Kimberly, Haddock Elaine, Feldmann Heinz, de Wit Emmie
Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana, United States of America.
PLoS Negl Trop Dis. 2016 Nov 3;10(11):e0005120. doi: 10.1371/journal.pntd.0005120. eCollection 2016 Nov.
Nipah virus causes respiratory and neurologic disease with case fatality rates up to 100% in individual outbreaks. End stage lesions have been described in the respiratory and nervous systems, vasculature and often lymphoid organs in fatal human cases; however, the initial target organs of Nipah virus infection have not been identified. Here, we detected the initial target tissues and cells of Nipah virus and tracked virus dissemination during the early phase of infection in Syrian hamsters inoculated with a Nipah virus isolate from Malaysia (NiV-M) or Bangladesh (NiV-B).
METHODOLOGY/PRINCIPAL FINDINGS: Syrian hamsters were euthanized between 4 and 48 hours post intranasal inoculation and tissues were collected and analyzed for the presence of viral RNA, viral antigen and infectious virus. Virus replication was first detected at 8 hours post inoculation (hpi). Nipah virus initially targeted type I pneumocytes, bronchiolar respiratory epithelium and alveolar macrophages in the lung and respiratory and olfactory epithelium lining the nasal turbinates. By 16 hpi, virus disseminated to epithelial cells lining the larynx and trachea. Although the pattern of viral dissemination was similar for both virus isolates, the rate of spread was slower for NiV-B. Infectious virus was not detected in the nervous system or blood and widespread vascular infection and lesions within lymphoid organs were not observed, even at 48 hpi.
CONCLUSIONS/SIGNIFICANCE: Nipah virus initially targets the respiratory system. Virus replication in the brain and infection of blood vessels in non-respiratory tissues does not occur during the early phase of infection. However, virus replicates early in olfactory epithelium and may serve as the first step towards nervous system dissemination, suggesting that development of vaccines that block virus dissemination or treatments that can access the brain and spinal cord and directly inhibit virus replication may be necessary for preventing central nervous system pathology.
尼帕病毒可引发呼吸道和神经系统疾病,在个别疫情爆发中病死率高达100%。在致命的人类病例中,已描述了呼吸系统、神经系统、脉管系统以及通常还有淋巴器官的终末期病变;然而,尼帕病毒感染的初始靶器官尚未确定。在此,我们检测了尼帕病毒的初始靶组织和细胞,并追踪了接种来自马来西亚的尼帕病毒分离株(NiV-M)或孟加拉国的尼帕病毒分离株(NiV-B)的叙利亚仓鼠在感染早期病毒的传播情况。
方法/主要发现:在鼻内接种后4至48小时对叙利亚仓鼠实施安乐死,收集组织并分析病毒RNA、病毒抗原和传染性病毒的存在情况。接种后8小时首次检测到病毒复制。尼帕病毒最初靶向肺中的I型肺细胞、细支气管呼吸上皮和肺泡巨噬细胞,以及鼻甲内衬的呼吸道和嗅觉上皮。到接种后16小时,病毒扩散到喉和气管内衬的上皮细胞。尽管两种病毒分离株的病毒传播模式相似,但NiV-B的传播速度较慢。在神经系统或血液中未检测到传染性病毒,即使在接种后48小时也未观察到淋巴器官内广泛的血管感染和病变。
结论/意义:尼帕病毒最初靶向呼吸系统。在感染早期,病毒不会在大脑中复制,也不会感染非呼吸组织中的血管。然而,病毒在嗅觉上皮中早期复制,可能是向神经系统传播的第一步,这表明开发能够阻断病毒传播的疫苗或能够进入脑和脊髓并直接抑制病毒复制的治疗方法对于预防中枢神经系统病变可能是必要的。